type 2 diabetes, normal subject
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Those who are not taking anti-hyperlipidemic medicine. Those who are not under insulin therapy.
Exclusion criteria
Exclusion criteria: Those who suffer from critical illness (liver diseases, kidney diseases, heart diseases, malignancies, etc.) Those who suffer from collagen diseases. Those who suffered from acute inflammatory diseases during the past 2 weeks. Those who are pregnant, breast-feeding, or have the probability of pregnancy. Those whose HbA1c values are more than 7.5%.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| First, we measure the levels of several sterols with FPLC using human plasma samples. Then, we will analyze the association of these sterol values with the markers for insulin resistance (HOMA-IR, adiponectin levels, etc) and the markers for inflammation (high sensitive CRP, TNFa, bioactive phospholipids, etc). | — |
Countries
Japan
Contacts
Fukushima Medical University, Aizu Medical Center Department of Metabolism, Diabetes and Nephrology